×

Mylan shares fall on EpiPen pricing

12:45 PM ET Tue, 23 Aug 2016

The "FMHR" traders and Stephanie Link, TIAA Global Asset Management, discuss Mylan's EpiPen pricing saga and whether it's a new catalyst to sell Biotech.